The Latin America, Middle East and Africa Diabetic Footwear Market would witness market growth of 10.0% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 16,517.1 thousand Units, showcasing a growth of 11.6% (2023-2030).
The market has grown substantially over the past decade, driven by the rising prevalence of diabetes and a growing awareness of the importance of foot care in diabetic patients. Diabetes, a chronic metabolic disorder, often leads to various complications, including peripheral neuropathy and poor blood circulation. These complications can significantly impact the lower extremities, making the diabetic population more susceptible to foot-related issues. In response, the market has emerged as a critical component of diabetic care, providing innovative solutions to address the unique needs of individuals with diabetes.
Moreover, one of the primary reasons for adopting diabetic footwear is its role in preventing and managing diabetic foot complications. Individuals with diabetes are prone to neuropathy, which reduces sensation in the feet, and peripheral artery disease, leading to poor blood circulation. These factors can result in foot ulcers and infections. Diabetic footwear is specifically engineered to minimize pressure points, reduce friction, and provide adequate support, thus preventing the development of ulcers and minimizing the risk of amputations.
Additionally, as per the data from the IDF, in 2021, 4.2 million people had diabetes in South Africa, and by 2045, the numbers are projected to rise to 7.4 million. Likewise, the prevalence of diabetes in Saudi Arabia is expected to increase from 4.2 million in 2021 to 7.5 million by 2045, according to the same source. Hence, with growing cases of diabetes in many countries of LAMEA, the demand for diabetic shoes is expected to grow rapidly in the region.
The Brazil market dominated the LAMEA Diabetic Footwear Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $227.9 Million by 2030. The Argentina market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 9.7% during (2023 - 2030).
Based on End User, the market is segmented into Women and Men. Based on Type, the market is segmented into Shoes, Sandals and Slippers. Based on Distribution Channel, the market is segmented into Specialty Stores, Online Platform, Footwear Stores and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
The market has grown substantially over the past decade, driven by the rising prevalence of diabetes and a growing awareness of the importance of foot care in diabetic patients. Diabetes, a chronic metabolic disorder, often leads to various complications, including peripheral neuropathy and poor blood circulation. These complications can significantly impact the lower extremities, making the diabetic population more susceptible to foot-related issues. In response, the market has emerged as a critical component of diabetic care, providing innovative solutions to address the unique needs of individuals with diabetes.
Moreover, one of the primary reasons for adopting diabetic footwear is its role in preventing and managing diabetic foot complications. Individuals with diabetes are prone to neuropathy, which reduces sensation in the feet, and peripheral artery disease, leading to poor blood circulation. These factors can result in foot ulcers and infections. Diabetic footwear is specifically engineered to minimize pressure points, reduce friction, and provide adequate support, thus preventing the development of ulcers and minimizing the risk of amputations.
Additionally, as per the data from the IDF, in 2021, 4.2 million people had diabetes in South Africa, and by 2045, the numbers are projected to rise to 7.4 million. Likewise, the prevalence of diabetes in Saudi Arabia is expected to increase from 4.2 million in 2021 to 7.5 million by 2045, according to the same source. Hence, with growing cases of diabetes in many countries of LAMEA, the demand for diabetic shoes is expected to grow rapidly in the region.
The Brazil market dominated the LAMEA Diabetic Footwear Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $227.9 Million by 2030. The Argentina market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 9.7% during (2023 - 2030).
Based on End User, the market is segmented into Women and Men. Based on Type, the market is segmented into Shoes, Sandals and Slippers. Based on Distribution Channel, the market is segmented into Specialty Stores, Online Platform, Footwear Stores and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, USD Billion/Million, 2019-2030)- Women
- Men
- Shoes
- Sandals
- Slippers
- Specialty Stores
- Online Platform
- Footwear Stores
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- New Balance Athletics, Inc.
- SKECHERS USA, Inc.
- Orthofeet, Inc. (Webster Equity Partners)
- DJO Global (Enovis Corporation)
- Drew Shoe Corporation
- Wolverine World Wide, Inc.
- Podartis Srl
- I-Runner (Healer Health LLC)
- Pilgrim Shoes
- Aetrx Worldwide, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Diabetic Footwear Market by End User
Chapter 6. LAMEA Diabetic Footwear Market by Type
Chapter 7. LAMEA Diabetic Footwear Market by Distribution Channel
Chapter 8. LAMEA Diabetic Footwear Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- New Balance Athletics, Inc.
- SKECHERS USA, Inc.
- Orthofeet, Inc. (Webster Equity Partners)
- DJO Global (Enovis Corporation)
- Drew Shoe Corporation
- Wolverine World Wide, Inc.
- Podartis Srl
- I-Runner (Healer Health LLC)
- Pilgrim Shoes
- Aetrx Worldwide, Inc.
Methodology
LOADING...
